Robert L. Ferrara

CIK: 0001792987

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PHIO

Phio Pharmaceuticals Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

PHIO
Phio Pharmaceuticals Corp.
Sep 11, 2025
Award(A)
Direct
23.1K shares-
PHIO
Phio Pharmaceuticals Corp.
Sep 11, 2025
Award(A)
Direct
23K shares-
PHIO
Phio Pharmaceuticals Corp.
Jun 10, 2025
Purchase(P)
Direct
2.5K shares at avg. $2.42$6K
PHIO
Phio Pharmaceuticals Corp.
May 20, 2025
Purchase(P)
Direct
2.5K shares at avg. $1.82$5K
PHIO
Phio Pharmaceuticals Corp.
Sep 11, 2024
Award(A)
Direct
10K shares-

		Type	Shares	Price		Ownership
Sep 11, 2025	PHIO Phio Pharmaceuticals Corp.	Award(A)	23,100	-	-	Direct
Sep 11, 2025	PHIO Phio Pharmaceuticals Corp.	Award(A)	23,000	-	-	Direct
Jun 10, 2025	PHIO Phio Pharmaceuticals Corp.	Purchase(P)	2,500	$2.42	$6,050	Direct
May 20, 2025	PHIO Phio Pharmaceuticals Corp.	Purchase(P)	2,500	$1.82	$4,550	Direct
Sep 11, 2024	PHIO Phio Pharmaceuticals Corp.	Award(A)	10,000	-	$0	Direct

1-5 of 5 transactions

About Ferrara Robert L

Ferrara Robert L (SEC CIK 0001792987) files insider reports with the SEC as Director of Phio Pharmaceuticals Corp. (PHIO).

Signal8 holds 5 ownership filings by Ferrara Robert L, all Form 4s, filed between Sep 12, 2024 and Sep 15, 2025. Those filings report 5 transactions, from Sep 11, 2024 to Sep 11, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Ferrara Robert L's filings is in MARLBOROUGH, MA.

Recent filings by Ferrara Robert L

Sep 11, 2025: Grants or awards of PHIO shares (2 lines, Form 4, code A).
Jun 10, 2025: Open-market purchase of PHIO shares (Form 4, code P).
May 20, 2025: Open-market purchase of PHIO shares (Form 4, code P).
Sep 11, 2024: Grant or award of PHIO shares (Form 4, code A).

Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)

Carson Lisa Cabott, Chief Financial Officer
Bitterman Robert J, Chairman, Pres. & CEO
Plott Ronald Todd, Director
BRADFORD PATRICIA A, Director
Lockshin Curtis, Director
Freeman Jonathan E, Director

How to read Form 4 transaction codes